Welcome to this week’s Pandora Report! This issue examines the growing importance of local capacity in biodefense, the detection of H5N1 on a U.S. mink farm, and emerging questions at the intersection of AI, biotechnology, and biological security.
Join the Chemical Weapons Convention Coalition and Arms Control Association for a virtual briefing, “Syria’s Chemical Weapons Legacy: Current Issues and Challenges,” on September 16 at 11:00 AM-12:30 PM ET. The event will examine Syria’s ongoing efforts to address the chemical weapons legacy of the Assad regime.
The Elephant in the Room: Biodefense Goes Local—or Outbreaks Go Viral
By Carmen Shaw, Pandora Report Managing Editor
Source: Pexels.
Washington has long approached biodefense through a centralized, top-down approach, with federal agencies setting national priorities and strategies. However, recent outbreaks expose a critical vulnerability in that model: national biodefense is only as resilient as the local systems that carry it out. During this year’s cyclospora outbreak, Michigan investigators waited 12 days for Taco Bell supply chain records that a delayed FDA traceability rule would have required within 24 hours – a delay compounded by staffing shortages and an estimated $5.8 billion cut to CDC grant funding since last year. Meanwhile, Michigan was tracking more than 12,000 cyclospora cases while the national count stood at just 145.
The answer is not to abandon federal leadership, but to strengthen frontline capacity at the state and local levels. On Sep. 1, ASPR and NETEC announced a second round of STAND Awards, adding 21 hospitals across 16 states and territories to the National Special Pathogen System (NSPS), bringing the network to 75 facilities. In Bethel, Alaska, the Yukon-Kuskokwim Health Corporation has demonstrated how a tribal health system can build its own wastewater surveillance capacity, detecting influenza A up to 10 days before clinical data confirmed it and identifying rising COVID-19 and RSV activity. Uganda offers another example: during the 2026 Bundibugyo virus outbreak, the country met all three WHO 7-1-7 outbreak response benchmarks, detecting the outbreak in six days, notifying authorities in under one day, and completing early response actions within two days.
True biodefense preparedness requires federal leadership to actively strengthen state, local, tribal, and regional capacity, ensuring people and institutions are ready to detect and respond where threats first emerge.
Further Reading:
- “75 Hospitals and Counting: Federal Program Expands the Nation’s Frontline Defense Against Deadly Pathogens,” Global Biodefense
- “‘Transformation’ Project Underway at CDC,” Kristina Fiore, MedPage Today
- “Annenberg poll: Americans trust their doctors when it comes to public health, but not FDA, CDC,” Stephanie Soucheray, CIDRAP
H5N1 Arrives on U.S. Mink Farms
By Margeaux Malone, Pandora Report Associate Editor
The USDA confirmed avian influenza H5N1 on a Utah mink farm in mid-August, marking the virus’s first detection in a U.S. mink operation. Scientists have long flagged farmed mink as a potential pandemic risk as the size and density of the farms create a perfect environment in which the virus can mutate. An H5N1 outbreak in Spain in 2022 infected tens of thousands of minks and demonstrated the first documented evidence of mammal-to-mammal spread. Minks also have very similar respiratory systems to humans, creating conditions that researchers warn could help the virus evolve toward person-to-person transmission. Unfortunately, the concern isn’t purely theoretical. During the Covid-19 pandemic, mutated coronavirus strains circulated on fur farms across several European countries, and Denmark reported a dozen farm workers infected with a mink-linked variant that was less responsive to vaccines.
In addition to ethical and economic reasons, the zoonotic disease risk from farmed mink has already prompted most European countries to shut down or phase out fur farming. The U.S., however, has no federal ban on mink farming, and states including Utah, Wisconsin, and Minnesota still operate dozens of farms housing up to 12,000 animals apiece. Roughly 1.3 million pelts a year are produced in the U.S. for export, largely to Chinese fashion manufacturers. In response to the Utah detection, animal welfare groups are now pressing the USDA to phase out mink farming entirely, citing both the animal welfare concerns of the industry and its potential role as a breeding ground for the next pandemic virus.
Screwworm Zones Lifted in Texas
On a more encouraging note, USDA APHIS announced the release of two New World screwworm (NWS)-infested zones in Texas after coordinated surveillance, sterile fly releases, and livestock movement restrictions met federal criteria. It’s the first such release since the re-emergence of NWS in Texas in early June. The move lifts NWS-related movement requirements for producers in those zones, though other infested areas remain under restriction as the state-federal response continues. No new cattle infestations were detected in August in the U.S., but that does not mean NWS is disappearing just yet. Texas confirmed four new cases in domestic species in August: two in sheep, one in goats, and, most recently, in a dog detected on Monday, August 31st. Three of these cases remain active as of this week.
Further Reading:
- “Bird Flu Detections Resume in US Dairy Herds and Poultry Flocks After a Month Without Federal Updates,” Dorothy Brooks, Medical Daily
- “Dolphin dies from H5 bird flu in SA as researchers withdrawn from sub-Antarctic island over ‘psychosocial risk’,” Lisa Cox, The Guardian
- “Inside the Fight Against a Flesh-Eating Fly in Mexico,” James Wagner, The New York Times
Schar School Professor Examines AI and Biological Weapons Risks
Dr. Sonia Ben Ouagrham-Gormley, Associate Professor of the Biodefense Graduate Program at George Mason University’s Schar School of Policy and Government, examines the “de-skilling” narrative surrounding AI and biological weapons policy in a new article for the Georgetown Journal of International Affairs. She argues that assessments of AI-driven biological threats often overestimate the ability of AI and other emerging technologies to lower barriers to biological weapons development while underestimating the importance of tacit knowledge, integration across stages of development, and the challenges of constructing durable sociotechnical systems. Ouagrham-Gormley calls for more empirically grounded threat assessments that consider the full bioweapons development process and inform targeted policy responses.
IN OTHER NEWS
Biosafety, Biosecurity, and Biotechnology
- “Can AI create cures without building bioweapons?” WP Intelligence
- “A Proposed Biosafety Rewrite Could Reshape Oversight for Every US Lab,” Global Biodefense
- “Part I: Biotechnology in U.S.-China Competition: A Conversation with Senator Todd Young,” CSIS
- “Part II: Biotechnology in U.S.-China Competition: A Conversation with Caitlin Frazer,” CSIS
- “AI & CBRN risks,” Conor Griffin and Victoria Langston, AI Policy Perspectives Substack
- “Battelle Advances Biothreat Detection with Novel Spray-Based Technology Developed for Defense Applications,” Battelle
- “NSCEB Releases Analysis for Securing U.S. Leadership in Brain-Computer Interfaces,” NSCEB
- “They Came for the Geneticists? Why Scientists See the New Genetic Data Law as a Threat to Russian Science,” T-Invariant
- “Major pathogenic threats in France and worldwide,” Pasteur Institute
Public Health, CDC and Health Security
- “We quit the CDC last year. The problems we protested remain,” Debra Houry, Daniel Jernigan, and Demetre Daskalakis, StatNews
- “Secretive deals may cut billions from U.S. global health spending, analysis shows,” Adam Taylor, WP
- “Trump admin to ‘radically’ cut health aid in 18 countries, report says,” Sara Jerving, Devex
Emerging Infectious Diseases and Outbreaks
- “Congo begins vaccinations to fight the fastest-growing Ebola outbreak in history,” AP News
- “Ebola outbreak in eastern Congo spreads to 2 new health zones with a total of 60 areas now affected,” Associated Press, WP
- “Notes from the Field: Characteristics and Monitoring of the 2026 Outbreak of Ebola Disease Caused by Bundibugyo Virus — Democratic Republic of the Congo, August 2026,” CDC
NEW: Bloomsday 2026
From Biotic: “Bloomsday 2026 will bring together researchers, ethicists, and policymakers to explore the emerging field of synthetic-cell engineering and the foundations needed to make the technology safe, reliable, and broadly accessible. The program will examine genome construction, computational tools, safety and security, dual-use risks, governance, and the ethical implications of engineered cellular systems.”
The event will take place on Thursday, September 10, 9:15 AM – 6:00 PM ET at the Science History Institute in Philadelphia. Learn more and register here.
NEW: Bioeconomy Summit
The Bioeconomy Summit, hosted by TechConnect, will bring together industry leaders, investors, federal officials, and experts to examine how the United States can strengthen and scale its bioeconomy. The summit will focus on aligning capital, policy, infrastructure, procurement, and industrial capacity; addressing vulnerabilities in biomanufacturing supply chains; and accelerating the deployment of bioindustrial technologies.
The summit will take place on Monday-Tuesday, September 21-22, at the National Harbor in Maryland. Learn more and register here.
NEW: Science of Evaluation of Artificial Intelligence for Life Sciences and Biotechnology Conference
From the National Academies: “This meeting brings together researchers and practitioners across various fields to define the emerging scientific method for artificial intelligence, focusing on benchmarks, leaderboards, challenges, and the evidence needed to trust systems that reason, act, discover, and operate in high-stakes domains, including the life sciences and biotechnology sectors.”
This conference will take place on Tuesday-Wednesday, September 22-23. Learn more and register here.
NEW: The Second Bio-Responsibility Policy Lecture: “From Lab Safety to Bio-Responsibility: Building the Human Infrastructure for Safe and Secure Science.”
From organizers: “Advances in the life sciences are creating new opportunities for health, biotechnology, and economic development while also presenting increasingly complex biosafety and biosecurity challenges. The lecture will examine how institutions can develop practical, risk-based biorisk management systems, with a focus on the trained professionals and institutional capacity needed to translate policy into practice. It will also explore approaches to expanding biorisk management capacity through scalable training, competency development, and institutional support, including in resource-constrained settings.”
The virtual lecture will take place on Thursday, September 24, 8:00 AM – 9:15 AM ET. Learn more and register here.
NEW: Frontiers in Synthetic Biology: SpudCells, Mirror Life and Societal Implications
From the Consortium on Law and Values: “Advances in cell engineering and synthetic biology offer enormous potential benefits, while raising ethical and policy issues. SpudCell, the first synthetic cell that can grow and reproduce, built from non-living chemicals, was developed by a team at the University of Minnesota. Scientists have cautioned against creating organisms with molecules that are mirror images of the biological components of known life, as existing organisms would have no immune defenses. Join three experts on synthetic biology, biosecurity, and bioethics to explore how to realize the promise of synthetic biology while controlling potential risks.”
This webinar will take place on Thursday, October 29, 3:00 PM ET. Learn more and register here.
Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB)
From the Office of the Assistant Secretary for Health (OASH): “The 28th PACCARB public meeting will explore how microbiome science can support AMR prevention, drive novel interventions, and build public awareness and understanding of microbiome-focused health measures. The meeting will focus on innovative and emerging topics in antimicrobial resistance (AMR) and the microbiome.”
This hybrid meeting will take place on September 9-10 from 9:00 AM–5:00 PM ET. Learn more and register here.
Exponential AI and Biotech Growth: Translating Technical to Policy – Workshop
From AI for SynBio: “The continued acceleration of agentic artificial intelligence (AI), Biological Design Tools (BDTs), and Biological AI Models (BAIMs) has transformed the technological landscape, enabling tremendous benefits and potential misuse that could massively impact national security, defense, health, and economy. Mitigating this risk will require collaboration across Government, Industry, and Academia with both technical and policy focuses. Significant effort, especially at the federal level, has been made to raise awareness of this challenge, yet additional discussion is necessary to keep pace with the ever-evolving speed of this global technology.’
This workshop will take place from September 15-17 at the Hopkins Bloomberg Center in Washington, DC. Learn more and register here.
Data and Situational Awareness for Medical and Public Health Preparedness and Response: A Workshop Series
From the National Academies: “The Forum on Medical and Public Health Preparedness for Disasters and Emergencies workshop series will explore how medical, public health, emergency management, and critical infrastructure data are collected, integrated, analyzed, and translated into real-time information to support timely, coordinated decision-making before, during, and after disasters and emergencies.”
This workshop series will take place on September 23. Learn more and register here.
International Bio-Responsibility Conference 2027
Organized under the Bio-Responsibility Initiative at the Centre for Society and Policy (CSP), the conference brings together people to advance dialogue, build partnerships, and promote safe, secure, and responsible life science research, development, and innovation. The conference will host experts, policymakers, and practitioners around the world to discuss emerging biological risks and ways to strengthen responsible governance.
The deadline to register is September 30. Learn more and register here.
Training Course on ‘Biotechnology Innovation and Biosecurity’
From the International Centre for Genetic Engineering and Biotechnology (ICGEB) and the Biological Weapons Convention Implementation Support Unit: “This training focuses on strengthening capacities in biosecurity, biosafety, and biological risk management in the context of rapid advances in biotechnology with an integrated, interdisciplinary approach to manage biothreats at the intersection of humans, animals, plants and the environment. It addresses the governance, technical, and operational dimensions of preventing, detecting, and responding to biological threats, while promoting responsible and peaceful scientific research and innovation in accordance with article X of the Biological Weapons Convention (BWC).”
This in-person event will be held from October 12-16 in New Delhi, India. Learn more and apply here.
Biomanufacturing for Defense & Security Summit
From Diversified Solutions Incorporated (DSI Groups): “This event will bring together senior thought leaders and stakeholders from across DoW, Military Research Labs, Federal Government, Commercial Industry, & Academia to discuss how each are advancing biomanufacturing to enhance national security objectives, produce critical materials for defense applications, and strengthen the overall U.S. bioindustrial manufacturing base. Biomanufacturing is crucial for U.S. national security because it enables domestic production of critical materials, medicines, and defense supplies, reducing reliance on foreign adversaries, which in turn creates resilient supply chains for the military and economy.”
This event will take place from October 27-28 at the National Harbor, MD. Learn more and register here.
The Pandora Report 